Skip to main content
IKT logo

IKT · Inhibikase Therapeutics, Inc. · Share Buybacks

Track IKT — free
$1.32 +0.02 (+1.54%) At close · Nov 20 Q2 2024 earnings call transcript
Market Cap
$185.16M
Shares
140.27M
Volume · Nov 20 1.11M Avg daily vol (3M) 580.26K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Remaining Authorization
$131,500,000
as of 2026-09-30

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2025-12-19 — — —
2025-06-20 $185,000,000 — —
Key facts CIK 1750149 CUSIP 45719W205 13F (30d) 109 filings 103 filers Visit website Investor relations